Literature DB >> 26373733

Tubb3 regulation by the Erk and Akt signaling pathways: a mechanism involved in the effect of arginine ADP-ribosyltransferase 1 (Art1) on apoptosis of colon carcinoma CT26 cells.

Ming Xiao1, Yi Tang1, Wen-Wen Chen1, Ya-Lan Wang2, Lian Yang1, Xian Li1, Guang-Lin Song1, Jing Kuang1.   

Abstract

The influence of the most important classical mono-ADP-ribosyltransferase, arginine ADP-ribosyltransferase 1 (Art1), on survival and apoptosis of colon carcinoma cells and the potential mechanisms have been partly discussed in our previous study but still need to be further studied. In this present study, Art1 of colon carcinoma CT26 cells was silenced with lentiviral vector-mediated short hairpin RNA (shRNA) or overexpressed with lentiviral vector-mediated complementary DNA (cDNA) and allograft transplant tumors are established in Balb/c mice. We verified Art1 knockdown increases apoptosis of CT26 cells transplant tumor; Art1 overexpression acts oppositely. Accordingly, growth of transplant tumors is inhibited in Art1 knockdown transplant tumors and increases in Art1 overexpression transplant tumors. Furthermore, activity of Akt and Erk cell signal pathways and expression of an apoptosis biomarker, βIII-tubulin (Tubb3), decrease when Art1 was silenced and increase when Art1 was overexpressed. Inhibiting Akt pathway or Erk pathway both downregulates expression of Tubb3 on protein and messenger RNA (mRNA) level, indicating that Tubb3 could be regulated by both Akt and Erk pathways, and plays a role in the influence of Art1 on apoptosis of Balb/c mice allograft transplant tumor. We also demonstrated that Bcl-2 family is not the responsible downstream factor of the Erk pathway in colon carcinoma cells which is undergoing apoptosis. These findings enrich the molecular mechanism for the function of Art1 in colon carcinoma and provide a complementary support for Art1 to be a potential therapeutic target of the treatment of this kind of malignant tumor.

Entities:  

Keywords:  Akt; Apoptosis; Art1; Erk; Tubb3

Mesh:

Substances:

Year:  2015        PMID: 26373733     DOI: 10.1007/s13277-015-4058-y

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  50 in total

1.  Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes.

Authors:  M Kavallaris; D Y Kuo; C A Burkhart; D L Regl; M D Norris; M Haber; S B Horwitz
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

Review 2.  Microtubules and resistance to tubulin-binding agents.

Authors:  Maria Kavallaris
Journal:  Nat Rev Cancer       Date:  2010-02-11       Impact factor: 60.716

3.  Gender influences the class III and V β-tubulin ability to predict poor outcome in colorectal cancer.

Authors:  Marisa Mariani; Gian Franco Zannoni; Stefano Sioletic; Steven Sieber; Candice Martino; Enrica Martinelli; Claudio Coco; Giovanni Scambia; Shohreh Shahabi; Cristiano Ferlini
Journal:  Clin Cancer Res       Date:  2012-03-21       Impact factor: 12.531

4.  Class III β-tubulin overexpression within the tumor microenvironment is a prognostic biomarker for poor overall survival in ovarian cancer patients treated with neoadjuvant carboplatin/paclitaxel.

Authors:  Dana M Roque; Natalia Buza; Michelle Glasgow; Stefania Bellone; Ileana Bortolomai; Sara Gasparrini; Emiliano Cocco; Elena Ratner; Dan-Arin Silasi; Masoud Azodi; Thomas J Rutherford; Peter E Schwartz; Alessandro D Santin
Journal:  Clin Exp Metastasis       Date:  2013-09-05       Impact factor: 5.150

5.  Antitumor activity and biochemical effects of aphidicolin glycinate (NSC 303812) alone and in combination with cisplatin in vivo.

Authors:  P J O'Dwyer; J D Moyer; M Suffness; S D Harrison; R Cysyk; T C Hamilton; J Plowman
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

Review 6.  Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update.

Authors:  C Soldani; A Ivana Scovassi
Journal:  Apoptosis       Date:  2002-08       Impact factor: 4.677

Review 7.  PARP-1 mechanism for coupling DNA damage detection to poly(ADP-ribose) synthesis.

Authors:  Marie-France Langelier; John M Pascal
Journal:  Curr Opin Struct Biol       Date:  2013-01-16       Impact factor: 6.809

8.  Combination of microtubule associated protein-tau and β-tubulin III predicts chemosensitivity of paclitaxel in patients with advanced gastric cancer.

Authors:  Jingwei Yu; Jing Gao; Zhihao Lu; Jifang Gong; Yanyan Li; Bin Dong; Zhongwu Li; Xiaotian Zhang; Lin Shen
Journal:  Eur J Cancer       Date:  2014-07-10       Impact factor: 9.162

Review 9.  PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.

Authors:  Andreína Peralta-Leal; José Manuel Rodríguez-Vargas; Rocío Aguilar-Quesada; María Isabel Rodríguez; José Luis Linares; Mariano Ruiz de Almodóvar; F Javier Oliver
Journal:  Free Radic Biol Med       Date:  2009-04-10       Impact factor: 7.376

10.  Integrin alpha 7 as substrate for a glycosylphosphatidylinositol-anchored ADP-ribosyltransferase on the surface of skeletal muscle cells.

Authors:  A Zolkiewska; J Moss
Journal:  J Biol Chem       Date:  1993-12-05       Impact factor: 5.157

View more
  6 in total

1.  TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer.

Authors:  Yohei Sekino; Xiangrui Han; Takafumi Kawaguchi; Takashi Babasaki; Keisuke Goto; Shogo Inoue; Tetsutaro Hayashi; Jun Teishima; Masaki Shiota; Wataru Yasui; Akio Matsubara
Journal:  Int J Mol Sci       Date:  2019-08-13       Impact factor: 5.923

2.  Exosomes from mesenchymal stem cells modulate endoplasmic reticulum stress to protect against nucleus pulposus cell death and ameliorate intervertebral disc degeneration in vivo.

Authors:  Zhiwei Liao; Rongjin Luo; Gaocai Li; Yu Song; Shengfeng Zhan; Kangcheng Zhao; Wenbin Hua; Yukun Zhang; Xinghuo Wu; Cao Yang
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556

3.  Exosomes Derived from Human Urine-Derived Stem Cells Inhibit Intervertebral Disc Degeneration by Ameliorating Endoplasmic Reticulum Stress.

Authors:  HongFei Xiang; WeiLiang Su; XiaoLin Wu; WuJun Chen; WenBin Cong; Shuai Yang; Chang Liu; ChenSheng Qiu; Shang-You Yang; Yan Wang; GuoQing Zhang; Zhu Guo; DongMing Xing; BoHua Chen
Journal:  Oxid Med Cell Longev       Date:  2020-12-07       Impact factor: 6.543

Review 4.  An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance.

Authors:  Amelia L Parker; Wee Siang Teo; Joshua A McCarroll; Maria Kavallaris
Journal:  Int J Mol Sci       Date:  2017-07-04       Impact factor: 5.923

5.  Targeted silencing of the ADP-ribosyltransferase 3 gene inhibits the migration ability of melanoma cells.

Authors:  Jie He; Yongyun Li; Ying Wang; He Zhang; Shengfang Ge; Xianqun Fan
Journal:  Oncol Lett       Date:  2018-03-13       Impact factor: 2.967

Review 6.  The Potential of Combining Tubulin-Targeting Anticancer Therapeutics and Immune Therapy.

Authors:  Alexis Fong; Amanda Durkin; Hoyun Lee
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.